Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Other Non Operating Income (2016 - 2025)

Palisade Bio has reported Other Non Operating Income over the past 15 years, most recently at $1.1 million for Q4 2025.

  • Quarterly Other Non Operating Income rose 2543.9% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, up 196.77% year-over-year, with the annual reading at $1.3 million for FY2025, 196.77% up from the prior year.
  • Other Non Operating Income was $1.1 million for Q4 2025 at Palisade Bio, up from $59000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $12.8 million in Q3 2021 and troughed at $41000.0 in Q4 2024.
  • The 5-year median for Other Non Operating Income is $188000.0 (2023), against an average of $1.3 million.
  • Year-over-year, Other Non Operating Income skyrocketed 1276300.0% in 2021 and then tumbled 96.66% in 2022.
  • A 5-year view of Other Non Operating Income shows it stood at $12.8 million in 2021, then tumbled by 98.97% to $131000.0 in 2022, then surged by 42.75% to $187000.0 in 2023, then crashed by 78.07% to $41000.0 in 2024, then skyrocketed by 2543.9% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for PALI's Other Non Operating Income are $1.1 million (Q4 2025), $59000.0 (Q3 2025), and $61000.0 (Q2 2025).